
Introducing TRHCROSS
the scienceof movement.
Cross-linked hyaluronic acid.
A considered approach to knee viscosupplementation, by i+Med.

2% · 4.4 mL
one formulation.
a precise purpose.
A cross-linked sodium hyaluronate hydrogel, developed for use in the knee joint.
Material study / conceptual illustrationEngineered as a hydrogel.
Biocompatible, cross-linked sodium hyaluronate obtained through biofermentation and highly purified. Supplied as a sterile injectable hydrogel.
Designed for the knee.
Intended for intra-articular viscosupplementation where osteoarthritis has reduced synovial fluid viscosity, in patients who have responded inadequately to conservative non-pharmacological therapy and simple analgesics.
Precision, pre-filled.
TRHCROSS 2% is presented in a sterile, graduated, disposable Type I glass syringe, pre-filled with 4.4 mL of solution.
For administration by qualified healthcare professionals. Refer to the official product information and instructions for use.
small scale.
deep thinking.
At i+Med, research into hydrogels, smart nanohydrogels and controlled release technologies shapes a new generation of biomedical solutions.
Discover the product details ↗Shop i+Med

Showing 1 of 1

